Brian P. Niland

发表

Regulation of immunotherapeutic products for cancer and FDA’s role in product development and clinical evaluation

R. Puri, M. Theoret, S. R. Husain, 2013, Journal of Immunotherapy for Cancer.

CD8 T Cell-Mediated HLA-A*0201-Restricted Cytotoxicity to Transaldolase Peptide 168–176 in Patients with Multiple Sclerosis

A. Perl, W. Biddison, K. Bánki, 2005 .

Patients Retention of Antigenicity for Multiple Causes the Loss of Enzymatic Activity with Cleavage of Transaldolase by Granzyme B

J. Lieberman, A. Perl, A. Rosen, 2010 .

Persistent Mitochondrial Hyperpolarization, Increased Reactive Oxygen Intermediate Production, and Cytoplasmic Alkalinization Characterize Altered IL-10 Signaling in Patients with Systemic Lupus Erythematosus1

A. Perl, P. Gergely, P. Phillips, 2002, The Journal of Immunology.

Deletion of Ser-171 causes inactivation, proteasome-mediated degradation and complete deficiency of human transaldolase.

S. Vajda, A. Perl, M. S. van der Knaap, 2004, The Biochemical journal.

Assessment of risk of variant creutzfeldt‐Jakob disease (vCJD) from use of bovine heparin

Hong Yang, S. Anderson, D. Keire, 2020, Pharmacoepidemiology and drug safety.

Differential regulation of hydrogen peroxide and Fas-dependent apoptosis pathways by dehydroascorbate, the oxidized form of vitamin C.

A. Perl, P. Gergely, K. Bánki, 2002, Antioxidants & redox signaling.

Evaluation of autoimmunity to transaldolase in multiple sclerosis.

A. Perl, Brian P. Niland, 2004, Methods in molecular medicine.

Dystonia-causing mutant torsinA inhibits cell adhesion and neurite extension through interference with cytoskeletal dynamics

X. Breakefield, D. Bragg, J. Zeng, 2006, Neurobiology of Disease.

Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus.

A. Perl, P. Gergely, P. Phillips, 2002, Arthritis and rheumatism.

Cancer Immunotherapy Principles and Practice

Ke Liu, Pedro Romero, Patricia A. Young, 2018 .

TorsinA binds the KASH domain of nesprins and participates in linkage between nuclear envelope and cytoskeleton

A. Sonnenberg, X. Breakefield, D. Irimia, 2008, Journal of Cell Science.

Regulation of CD4 Expression via Recycling by HRES-1/RAB4 Controls Susceptibility to HIV Infection*

G. Nagy, Á. Koncz, Tiffany Telarico, 2006, Journal of Biological Chemistry.

Cleavage of Transaldolase by Granzyme B Causes the Loss of Enzymatic Activity with Retention of Antigenicity for Multiple Sclerosis Patients

J. Lieberman, D. Martinvalet, A. Perl, 2010, The Journal of Immunology.

siRNA knock-down of mutant torsinA restores processing through secretory pathway in DYT1 dystonia cells.

X. Breakefield, B. Tannous, P. Hadwiger, 2008, Human molecular genetics.

Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells

X. Breakefield, B. Tannous, J. Zeng, 2007, Proceedings of the National Academy of Sciences.

CD8+ T Cell-Mediated HLA-A*0201-Restricted Cytotoxicity to Transaldolase Peptide 168–176 in Patients with Multiple Sclerosis1

A. Perl, W. Biddison, K. Bánki, 2005, The Journal of Immunology.

Transaldolase deficiency influences the pentose phosphate pathway, mitochondrial homoeostasis and apoptosis signal processing.

F. Middleton, D. Karp, G. Nagy, 2008, The Biochemical journal.

Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus.

A. Perl, E. Bonilla, Brian P. Niland, 2006, Arthritis and rheumatism.

Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine.

F. Middleton, S. Landas, G. Vas, 2009, The Journal of clinical investigation.

Transaldolase haploinsufficiency in subjects with acetaminophen‐induced liver failure

William M. Lee, A. Perl, L. Szőnyi, 2019, Journal of inherited metabolic disease.

This information is current as Sclerosis Patients Retention of Antigenicity for Multiple Causes the Loss of Enzymatic Activity with Cleavage of Transaldolase by Granzyme B

J. Lieberman, D. Martinvalet, A. Perl, 2010 .